Androgenetic Alopecia in Fabry Disease

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

NCT03898479 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

NCT04784533 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

NCT07133308 ·Status: RECRUITING ·Phase: PHASE3

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

NCT02553330 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata

NCT05556265 ·Status: TERMINATED ·Phase: PHASE2

A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings

NCT07200128 ·Status: COMPLETED

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata

NCT04011748 ·Status: UNKNOWN ·Phase: PHASE2

Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia

NCT00691769 ·Status: COMPLETED

Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata

NCT05910138 ·Status: UNKNOWN ·Phase: NA

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

NCT03495817 ·Status: COMPLETED ·Phase: PHASE2

Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis

NCT02299297 ·Status: COMPLETED ·Phase: PHASE2

Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia

NCT06854432 ·Status: TERMINATED ·Phase: NA

Tofacitnib for the Treatment of Alopecia Areata and Variants

NCT02197455 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia

NCT05332366 ·Status: COMPLETED ·Phase: PHASE2

Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia

NCT02848300 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata

NCT03941548 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata

NCT03137381 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age

NCT05650333 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

NCT07029711 ·Status: RECRUITING ·Phase: PHASE3

Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

NCT06501924 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

NCT07029828 ·Status: RECRUITING ·Phase: PHASE3

Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis

NCT01314495 ·Status: WITHDRAWN ·Phase: PHASE2

Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia

NCT05076006 ·Status: COMPLETED ·Phase: PHASE2

Harnessing Artificial Intelligence for Diagnosing Androgenetic Alopecia: A Training and Validation Study

NCT07294313 ·Status: NOT_YET_RECRUITING

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

NCT06873945 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3